Arbutus Biopharma Corp (ABUS)
3.46 x 1 3.50 x 9
Post-market by (Cboe BZX)
3.50 +0.23 (+7.03%) 03/28/25 [NASDAQ]
3.46 x 1 3.50 x 9
Post-market 3.56 +0.06 (+1.71%) 16:08 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ABUS | CVAC | AVBP | ||
| Company | Arbutus Biopharma Corp | Curevac N.V. | Arrivent Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.27 | 3.29 | 18.52 | ||
| High | 3.54 | 3.33 | 19.04 | ||
| Low | 3.26 | 2.96 | 18.41 | ||
| Last | 3.50 | 2.98 | 18.95 | ||
| Change | +0.23 | +0.18 | +0.38 | ||
| % Change | +7.03% | +6.43% | +2.05% | ||
| Volume | 1,444,500 | 2,036,900 | 121,100 | ||
| 20-Day Average Volume | 989,540 | 606,685 | 191,705 | ||
| Previous Close | 3.27 | 2.80 | 18.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.31 | 3.02 | 20.66 | ||
| 20-Day Raw Stochastic | 87.27% | 36.36% | 18.40% | ||
| 20-Day Relative Strength | 55.86% | 44.66% | 32.58% | ||
| Weighted Alpha | +9.18 | -17.06 | -12.99 | ||
| Today's Opinion | 48% Sell | 40% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 48% Sell | 88% Sell | ||
| Last Month's Opinion | 48% Sell | 24% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.71% since 03/21/25 | +3.11% since 03/21/25 | -2.92% since 03/21/25 | ||
| Low | 3.20 on 03/27/25 | 2.78 on 03/27/25 | 17.89 on 03/27/25 | ||
| High | 3.54 on 03/28/25 | 3.33 on 03/28/25 | 20.37 on 03/24/25 | ||
| 1-Month | |||||
| %Chg | +1.45% since 02/28/25 | -3.87% since 02/28/25 | -19.74% since 02/28/25 | ||
| Low | 3.02 on 03/12/25 | 2.78 on 03/27/25 | 17.89 on 03/27/25 | ||
| High | 3.57 on 03/04/25 | 3.33 on 03/28/25 | 23.65 on 03/03/25 | ||
| 3-Month | |||||
| %Chg | +9.03% since 12/27/24 | -5.99% since 12/27/24 | -30.48% since 12/27/24 | ||
| Low | 3.02 on 03/12/25 | 2.78 on 03/27/25 | 17.89 on 03/27/25 | ||
| High | 3.70 on 02/25/25 | 5.00 on 01/07/25 | 29.71 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -8.62% since 09/27/24 | -0.67% since 09/27/24 | -17.61% since 09/27/24 | ||
| Low | 3.02 on 03/12/25 | 2.37 on 11/20/24 | 17.89 on 03/27/25 | ||
| High | 4.35 on 10/16/24 | 5.00 on 01/07/25 | 36.37 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 663,222 | 667,162 | 644,603 | ||
| Shares Outstanding, K | 189,492 | 223,880 | 34,016 | ||
| Annual Sales | 18,140,000 | 58,180,000 | 0 | ||
| Annual Net Income | -72,850,000 | -281,580,000 | -80,490,000 | ||
| Last Quarter Sales | 1,340,000 | 543,090,000 | 0 | ||
| Last Quarter Net Income | -19,720,000 | 371,710,000 | -20,630,000 | ||
| 60-Month Beta | 1.93 | 2.53 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/06/24 | 1.65 on 11/12/24 | -0.60 on 03/03/25 | ||
| Latest Earnings Date | 05/01/25 | 04/23/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.09 | 0.00 | ||